Previous Article | Next Article 
Molecular and Cellular Biology, June 2001, p. 3725-3737, Vol. 21, No. 11
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.11.3725-3737.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Rfc4 Interacts with Rpa1 and Is Required for Both
DNA Replication and DNA Damage Checkpoints in Saccharomyces
cerevisiae
Hee-Sook
Kim and
Steven J.
Brill*
Department of Molecular Biology and
Biochemistry, Center for Advanced Biotechnology and Medicine,
Rutgers University, Piscataway, New Jersey 08854
Received 28 December 2000/Returned for modification 1 February
2001/Accepted 28 March 2001
 |
ABSTRACT |
The large subunit of replication protein A (Rpa1) consists of three
single-stranded DNA binding domains and an N-terminal domain (Rpa1N) of
unknown function. To determine the essential role of this domain we
searched for mutations that require wild-type Rpa1N for viability in
yeast. A mutation in RFC4, encoding a small subunit of
replication factor C (RFC), was found to display allele-specific interactions with mutations in the gene encoding Rpa1
(RFA1). Mutations that map to Rpa1N and confer sensitivity
to the DNA synthesis inhibitor hydroxyurea, such as
rfa1-t11, are lethal in combination with
rfc4-2. The rfc4-2 mutant itself is sensitive to hydroxyurea, and like rfc2 and rfc5 strains,
it exhibits defects in the DNA replication block and intra-S
checkpoints. RFC4 and the DNA damage checkpoint gene
RAD24 were found to be epistatic with respect to DNA damage
sensitivity. We show that the rfc4-2 mutant is defective in
the G1/S DNA damage checkpoint response and that both the
rfc4-2 and rfa1-t11 strains are defective in the G2/M DNA damage checkpoint. Thus, in addition to its
essential role as part of the clamp loader in DNA replication, Rfc4
plays a role as a sensor in multiple DNA checkpoint pathways. Our
results suggest that a physical interaction between Rfc4 and Rpa1N is required for both roles.
 |
INTRODUCTION |
Replication protein A (RPA) is a
highly conserved eukaryotic single-stranded DNA (ssDNA) binding protein
that was originally identified as a human factor required for simian
virus 40 (SV40) DNA replication in vitro (19, 84, 86). As
the eukaryotic equivalent of the Escherichia coli ssDNA
binding protein (Ecssb), RPA plays multiple roles in DNA metabolism,
including DNA replication, repair, and recombination (85).
In addition to participating in both the initiation and elongation of
DNA replication, RPA is required for nucleotide excision repair in
vitro and physically interacts with XPA, XPG, and XPF (30, 39,
62, 69). RPA is also required for genetic recombination and
physically interacts with Rad52 and other factors (1, 22, 47,
75).
RPA is a heterotrimeric complex. In the budding yeast
Saccharomyces cerevisiae it is composed of the Rpa1 (69 kDa), Rpa2 (36 kDa), and Rpa3 (13 kDa) subunits, which are encoded by
RFA1, RFA2, and RFA3, respectively. Each subunit
is essential for viability in yeast, and all three subunits are
required for SV40 DNA replication in vitro (12, 18, 25, 31,
32). Rpa1 exhibits strong ssDNA binding activity on its own, and
a subcomplex of Rpa2 and Rpa3 binds ssDNA weakly (7, 85).
We have shown that yeast Rpa1 consists of four functional domains: an
18-kDa N-terminal domain that lacks ssDNA binding activity (Rpa1N) and
three tandem ssDNA binding domains (SBDs; see Fig. 1A) (11,
56). SBD-A and SBD-B are structurally homologous as determined
by X-ray crystallographic analysis of human RPA (hRPA), while the
C-terminal domain (SBD-C) contains a C4-type zinc-finger motif
(6, 8, 11). These three ssDNA binding domains share amino
acid sequence similarity with each other and with the central region of
Rpa2 (11). All four domains of Rpa1, including Rpa1N, are
essential for viability in yeast (11, 56).
The essential function of Rpa1N is unknown but may involve its ability
to interact with other proteins. Human Rpa1N has been shown to bind DNA
polymerase
, p53, T antigen, and VP16 (10, 41).
Surprisingly, deletion of this domain in hRPA does not affect its ssDNA
binding activity or SV40 DNA replication in vitro (25,
35). In contrast, mutations in yeast Rpa1N result in defects in
DNA replication, recombination, and repair, and deletion of more than
10 amino acids from the N terminus is lethal (43, 56, 75).
To determine the essential cellular role of Rpa1N, we first isolated
the conditional mutation rfa1-Y29H, which maps to this
domain. We then performed a synthetic-lethal screen with rfa1-Y29H under permissive conditions to identify mutations
that require wild-type Rpa1N function for viability. To confirm that these synthetic-lethal mutations interacted specifically with Rpa1N, we
took advantage of a large collection of Rpa1 mutants (75).
The results indicate that one of the genes isolated in this screen,
RFC4, displays allele-specific interactions with mutations
mapping to Rpa1N.
Replication factor C (RFC), the eukaryotic clamp loader, loads the DNA
polymerase
processivity factor proliferating cell nuclear antigen
(PCNA, or sliding clamp) at primer-template junctions (37, 70,
72, 88). In the presence of RPA, the loading of PCNA by RFC
promotes a switch from synthesis by DNA polymerase
to processive
synthesis by DNA polymerase
(71, 74, 78, 89). RFC is a
heteropentameric complex consisting of one large subunit (Rfc1
[Cdc44]) and four small subunits (Rfc2, -3, -4, and -5), all of which
are essential for viability in yeast (15, 40). Mutations
in RFC2 and RFC5 cause sensitivity to the DNA synthesis inhibitor hydroxyurea (HU). Consistent with this phenotype and their role in DNA replication, these mutant strains display defects
in the DNA replication checkpoint pathway (50, 65, 66).
The four small subunits of RFC are also associated with Rad24, one of
the major components of the DNA damage checkpoint pathway (26,
27, 60). It has been proposed that the Rad24-Rfc2-5 complex is
responsible for loading a PCNA-like complex of Rad17-Mec3-Ddc1 at sites
of DNA repair (36, 76). Due to their association with
Rad24, the small subunits of RFC might also play a role in DNA damage
checkpoints. Indeed, defects in DNA damage checkpoints are exacerbated
in an rfc5 rad24 double mutant (48).
In this report we describe the isolation of the rfc4-2
mutation based on its synthetic lethality with a mutation in Rpa1N. We
find that the rfc4-2 mutant is sensitive to HU, is lethal in combination with Rpa1N mutations that are themselves HU sensitive, and
is partially defective in the replication block checkpoint response and
the intra-S DNA damage checkpoint. We also find that RFC4
functions in the RAD24 epistasis group and that
RFC4 plays a role in multiple DNA damage checkpoint
pathways. Taken together, the results suggest that both DNA replication
and DNA checkpoint signaling require a direct physical interaction
between Rfc4 and Rpa1N.
 |
MATERIALS AND METHODS |
Strains, media, and plasmid construction.
All yeast strains
used in this study are listed in Table 1.
Plasmids used in this study are listed in Table
2. Standard genetic techniques and
reagents were used in the construction, transformation, and growth of
yeast (57). The starting strains for the synthetic-lethal
screen, HSY657 and HSY672, were constructed by integrating pHS102,
containing the rfa1-Y29H allele, at the TRP1
locus of HSY631 and HSY626, respectively. Following loss of pJM195
(RFA1/URA3/ADE3) by growth on media containing
5-fluoroorotic acid (5-FOA), these strains displayed
temperature-sensitive (ts) growth. To reduce the probability of
obtaining rfa2 or rfa3 mutations in a
synthetic-lethal screen with rfa1-Y29H, second copies of RFA2 and RFA3 were provided by integrating pHS203
at the HIS3 locus of these strains.
Isolation of the rfa1-ts allele.
The region of
the RFA1 gene encoding the promoter and amino acids 1 to 200 was amplified under mutagenic PCR conditions using plasmid pDS1
(RFA1/LEU2/CEN) as a template (56). This DNA
was subjected to 35 cycles of amplification using Taq DNA
polymerase and specific primers in the presence of 1 mM
MnCl2. These randomly mutagenized PCR products were
combined with an RFA1 plasmid vector lacking the N-terminal
coding region of RFA1 (pDS1 digested with NdeI
and BamHI) and were cotransformed into strain SBY102
carrying plasmid pJM114 (RFA1/URA3/CEN). The RFA1
gene was repaired by homologous recombination in vivo. Leucine
prototrophs were selected and replica plated onto solid media
containing 5-FOA at 25°C to shuffle out the wild-type RFA1
plasmid, pJM114. FOA-resistant colonies were replica plated to yeast
extract-peptone-dextrose (YPD) plates and incubated at 25 or 37°C for
3 to 4 days. Approximately 20,000 colonies were screened for mutants
that failed to grow at 37°C. The plasmids from four ts strains were
rescued, and the transformation was repeated. One plasmid that was
found to reproducibly confer the ts growth phenotype was sequenced and
found to encode a single amino acid change at residue 29 from tyrosine
to histidine. An ApaI-SpeI fragment containing
the rfa1-Y29H mutation was subcloned into an otherwise
wild-type RFA1 gene to confirm that the ts phenotype was due
to the Y29H mutation.
Synthetic-lethal screen.
A red/white colony-sectoring assay
was used to identify mutations that were synthetically lethal with
rfa1-Y29H (4). To perform this screen, two
rfa1-Y29H strains (HSY657 and HSY672) carrying pJM195 and
showing the colony-sectoring phenotype were mutagenized with
ethylmethanesulfonate to approximately 30% viability. After 7 days of
growth at 25°C, approximately 100,000 colonies were screened for a
nonsectoring red colony phenotype. About 200 nonsectoring mutants were
obtained and rechecked for the nonsectoring phenotype by streaking on
YPD and were checked for lethality on 5-FOA, which selects against
uracil+ cells (i.e., cells that retain pJM195). The
following four experiments were performed on the 20 strains that passed
these tests. First, to determine whether these mutants required the
wild-type RFA1 gene or the pJM195 plasmid (which also
contains the URA3 and ADE3 marker genes), they
were transformed with pHS118 (RFA1/LEU2/CEN) or pHS119
(RFA1/LYS2/CEN) and were tested for the sectoring phenotype. Mutants that showed a nonsectoring phenotype were likely due to integration of ADE3 into a chromosome and were excluded by
this test. Second, the presence of rfa1-Y29H at the
TRP1 locus was confirmed by both PCR and complementation
testing. Genomic DNA was prepared and amplified by three sets of
oligonucleotides to confirm that the rfa1 mutant gene was
present at the TRP1 locus. Mutant strains were also crossed
to HSY635 or HSY636. Mutants that had lost rfa1-Y29H
produced diploids that required pJM195 and remained sensitive to 5-FOA
due to the lack of a chromosomal RFA1 gene. Third, the
synthetic-lethal mutations in these strains were shown to be recessive
by backcross to HSY657 or HSY672. Lastly, each backcrossed diploid was
sporulated and microdissected. The ratio of viable to inviable spores
was always near unity, indicating that the synthetic lethality was
caused by a single mutation. Three mutants passed these tests and were
found to represent three different complementation groups. These groups
were named slr51, slr157, and slr44, for
synthetically lethal with rpa1.
Cloning of RFC4.
To clone the wild-type copy of
slr51, the mutant strain was transformed with a yeast
genomic plasmid library (LEU2/CEN). The library plasmids
that complemented FOA-sensitive growth of slr51 were
recovered and sequenced. The overlapping regions of these chromosomal
fragments identified the complementing gene as RFC4. Genetic
linkage analysis was used to confirm that a mutation in RFC4
caused the synthetic-lethal phenotype with rfa1-Y29H. Strain HSY787, which contains a LEU2 marker integrated adjacent to
the RFC4 locus, was crossed to the slr51 strain,
and the diploid was sporulated and microdissected. Tetrad analysis
revealed that synthetic lethality and leucine auxotrophy always
segregated together. This mutant allele was named rfc4-2.
Allele specificity of rfc4-2.
To examine
allele-specific interactions between RFA1 and
RFC4, strain HSY740 (rfc4-2 rfa1
leu2 pJM195) was derived from a cross between HSY737 and
HSY635. A series of rfa1 mutant alleles in plasmid pRS415
(LEU2/CEN) were previously isolated by Umezu and colleagues
(63, 75). These plasmids were transformed into HSY740 and
HSY636 to create 19 rfc4-2 rfa1 double mutants and 19 rfa1 single mutants, each carrying pJM195. Cells were
scraped from plates and resuspended at an optical density at 600 nm of 3. Tenfold serial dilutions of cells were then prepared in a microtiter plate, and 5 µl of each dilution was transferred onto YPD plates or
synthetic complete media containing 5-FOA to measure synthetic lethality.
UV, MMS, and HU sensitivity.
To measure sensitivity to UV
light, cells were grown to early log phase. About 500 cells were spread
on YPD plates and were irradiated with the indicated levels of UV light
using a UV cross-linker (Stratagene). The number of viable cells was
determined by counting colonies after 3 days of growth, and the percent
viability compared to the unirradiated sample was calculated. To
determine methylmethanesulfonate (MMS) sensitivity, cells were grown in
liquid YPD and MMS was added to a final concentration of 0.1%. At the
indicated times, aliquots were removed and neutralized with an equal
volume of 10% sodium thiosulfate. The cells were then washed with
water and spread on YPD plates. The number of viable cells was
determined by counting colonies after 3 days of growth. To determine HU
sensitivity, cells were grown in liquid YPD and HU was added to a final
concentration of 200 mM. At the indicated times, aliquots were removed,
washed with water, and spread onto YPD plates. Viable cells were
determined as described above. HU sensitivity was also tested on solid
media by replica plating. HU was added to a final concentration of 100 mM to YPD agar or to the appropriate selective media. Fresh cells were
scraped from plates and were resuspended at an optical density at 600 nm of 3. Tenfold serial dilutions of cells were then prepared in a
microtiter plate, and 5 µl of each dilution was transferred onto
plates with and without HU.
Western blot assay for Rad53 phosphorylation.
Yeast cells
were grown to early log phase at 30°C. Exponentially growing cells,
cells synchronized in G1 for 2 h with
-factor (5 µg/ml), or cells arrested in G2 for 3 h with
nocodazole (20 µg/ml) were released into HU (200 mM)- or MMS
(0.1%)-containing media for 1 h. Alternatively, cells were
irradiated with 60 J of UV light/m2 and then were incubated
for 30 min. Cells treated with MMS were neutralized with 10% sodium
thiosulfate. To make whole cell extracts, 5 ml of each culture was
harvested, washed with water-20% trichloroacetic acid, and then
resuspended in 25 µl of 20% trichloroacetic acid. An equal volume of
glass beads was added, and cells were lysed by vortexing with glass
beads at 4°C. Whole cell extracts were microcentrifuged at 3,000 × g for 15 min at 4°C. Protein precipitates were resuspended
in 2× sodium dedocyl sulfate (SDS) loading buffer, heated for 5 min,
and then centrifuged at 3,000 × g for 5 min (51). Proteins were separated by SDS-10% polyacrylamide
gel electrophoresis (PAGE) and transferred to a nylon membrane. Rad53 proteins were detected with antiserum to Rad53 (90) and
horseradish peroxidase-conjugated anti-rabbit secondary antibody and
were visualized by a chemiluminescent developer (Amersham).
FACS analysis.
Yeast cells were grown to early log phase and
were synchronized in G1 with
-factor (5 µg/ml) for
2 h. Cells were washed with water and released into YPD or YPD
with 0.038% MMS. Aliquots of cells were removed every 30 min and
washed with an equal volume of 10% sodium thiosulfate to neutralize
the MMS. Cells were then fixed in 0.5 ml of water and 1.0 ml of 100%
ethanol solution by rotating overnight. Fixed cells were washed with 1 ml of 50 mM sodium citrate, were resuspended in 0.5 ml of 50 mM sodium
citrate containing 0.1 mg of RNase A/ml, and then were incubated for
2 h at 37°C. This cell suspension was added to 0.5 ml of 50 mM
sodium citrate containing 50 µg of propidium iodide/ml and was
incubated for at least 1 h at room temperature. DNA content was
analyzed on a Coulter-Epics fluorescence-activated cell sorter (FACS)
(46).
Rfc4-RPA binding assay.
Enzyme-linked immunosorbent assay
(ELISA) wells (Immulon) were coated with either 0.5 µg of RPA
complex, purified as described previously (13), or bovine
serum albumin (BSA) in incubation buffer (20 mM Tris-HCl [pH 7.5], 1 mM EDTA, 2 mM dithiothreitol, 5 mM MgCl2, 150 mM NaCl, 20%
glycerol, 2 mM CaCl2) for 1 h at 30°C. Wells were washed
three times with 1× PBST (29) and then blocked with 5%
dried milk in 1× PBST for 10 min at room temperature. 35S-labeled Rfc4 protein was expressed in an in vitro
transcription/translation system (Promega) and then was applied to a
Superdex 75 column. 35S-Rfc4 protein was eluted in buffer A
(25 mM Tris-HCl [pH 7.5], 1 mM EDTA, 0.01% NP-40, 10% glycerol, 0.1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol) containing 0.075 M NaCl and was collected. Purified 35S-labeled Rfc4 was
added into wells and incubated for 1 h at 30°C. Unbound Rfc4
protein was removed by washing three times with 1× PBST, and the bound
35S-Rfc4 was measured by scintillation counting.
 |
RESULTS |
Isolation of the conditionally lethal mutant
rfa1-Y29H.
As a first step to determine the essential
cellular role of the N-terminal domain of Rpa1 (Rpa1N), we isolated a
conditional-lethal RFA1 mutation mapping to this domain. A
strain lacking RFA1 was constructed and maintained by a copy
of RFA1 on a URA3-based plasmid. This strain,
SBY102 (rfa1
pJM114/RFA1/URA3/CEN), is unable
to grow on media containing 5-FOA since selection against the
URA3 plasmid is lethal in this background. Mutagenized
RFA1 fragments were introduced into this strain on
LEU2-based plasmids and were swapped for the RFA1
plasmid by replica plating on media containing 5-FOA at 25°C. About
20,000 colonies were screened for loss of viability at 37°C, and one
recessive rfa1-ts allele was isolated. DNA sequencing of
this allele revealed a mutation that changed tyrosine at residue 29 to
histidine. Hereafter, we refer to this allele as rfa1-Y29H.
As shown in Fig. 1A, rfa1-Y29H
and wild-type cells grew well at 25°C while the rfa1-Y29H
mutant showed a severe growth defect at 37°C. Additional
characterization of the rfa1-Y29H mutation revealed that its
function was partially compromised at the permissive temperature
because the mutant strain was weakly sensitive to UV or MMS treatment
at 25°C relative to the wild type (data not shown).

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 1.
Interacting alleles rfa1-Y29H and
rfc4-2. (A) A schematic diagram of Rpa1 is shown at the top.
To demonstrate the ts growth phenotype caused by rfa1-Y29H,
the strains HSY657 (rfa1-Y29H) and HSY679 (RFA1)
were streaked onto YPD plates and incubated at 25 or 37°C, as
indicated, for 3 days. (B) A schematic diagram of Rfc4 is shown
together with the location of the mutation encoded by rfc4-2
and the sequences of the surrounding region obtained from several Rfc4
homologs. To demonstrate the synthetic-lethal phenotype caused by
rfa1-Y29H and rfc4-2, the strains HSY657
(rfa1-Y29H) and HSY737 (rfa1-Y29H rfc4-2) were
streaked onto YPD or 5-FOA plates, as indicated, and were incubated at
25°C for 3 days. SBD, ssDNA binding domain; Zn, zinc-binding domain;
P-loop/DEAE, conserved motifs found in a large family of nucleoside
triphosphate-binding domains.
|
|
Isolation of rfc4-2 by its synthetic lethality with
rfa1-Y29H.
To identify mutants that require wild-type
Rpa1N for viability, we performed a synthetic-lethal screen with
rfa1-Y29H at 25°C. HSY657 and HSY672 are ade2
ade3 strains containing a stably integrated rfa1-Y29H
allele and plasmid pJM195 (RFA1/URA3/ADE3/CEN) (Table 1).
These strains allow the use of a red/white colony-sectoring assay to
measure plasmid stability since the starting strain is red
(ade2) and plasmid loss events generate white (ade2
ade3) sectors. About 100,000 ethylmethanesulfonate-mutagenized
colonies were screened for strains that require the pJM195 plasmid for viability and produce unsectored red colonies essentially as described previously (4). Three recessive slr (synthetic
lethal with rpa1) complementation groups were isolated. Because the
slr mutants require the wild-type RFA1 plasmid,
pJM195, for viability, they acquire a 5-FOA-sensitive phenotype (Fig.
1B). The mutation in slr51 was identified by transforming
the strain with a yeast genomic plasmid library and selecting strains
that no longer require pJM195 by growth on 5-FOA. The library plasmids
were rescued from the transformants, were sequenced, and were found to
contain the RFC4 gene. Linkage analysis confirmed that a
mutation in RFC4, hereafter referred to as
rfc4-2, caused the synthetic-lethal phenotype with rfa1-Y29H. The rfc4-2 allele was found to have a
single nucleotide change from G to A at residue 601, resulting in an
amino acid change of aspartate to asparagine at residue 201. This
mutation maps to the RFC box VIII/sensor2 motif, one of the conserved
motifs found in all RFC subunits (Fig. 1B) (15, 21, 40).
Compared to wild-type cells, the rfc4-2 single mutant showed
no obvious growth defects and grew well at temperatures ranging from 25 to 37°C. Thus, DNA replication is not significantly impaired by the
rfc4-2 mutation in the presence of wild-type RPA. To examine whether the rfc4-2 mutant has defects in DNA repair, we
measured its sensitivity to the DNA damaging agents UV and MMS.
Relative to the wild type, rfc4-2 was weakly sensitive to UV
but was more resistant than the known UV-sensitive strain
rfa1-t11 (75) (Fig. 2A). The rfc4-2 mutant was
very sensitive to MMS treatment (Fig. 2B). We conclude that Rfc4-2
function in response to DNA damage is compromised.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 2.
The rfc4-2 mutant is sensitive to DNA damage.
(A) UV sensitivity. Strains HSY636 (RFC4), HSY740
(rfc4-2), and HSY845 (rfa1-t11) were grown to
early log phase in liquid culture. A volume containing about 500 cells
was spread onto YPD plates and was irradiated with the indicated doses
of UV light. The percent viability was determined by counting colonies
following 3 days of growth. (B) MMS sensitivity. Cultures of HSY636
(RFC4) and HSY740 (rfc4-2) were grown to early
log phase in liquid YPD, and MMS was added to a final concentration of
0.1%. At the indicated times an aliquot of the culture was withdrawn,
the MMS was neutralized, and about 300 cells were spread onto YPD
plates. The percent viability was determined as described for panel
A.
|
|
Characterization of the Rfc4-Rpa1 interaction.
It has recently
been shown that the p140, p40, and p38 subunits of human RFC bind the
large subunit of human Rpa1 (89). Since yeast Rfc4 is the
homolog of p40, we tested whether there was a physical interaction
between Rfc4 and yeast RPA. For this experiment we used an ELISA-type
assay in which wild-type or mutant RPA complex or BSA control protein
was immobilized on the wells of a microtiter plate. These wells were
then incubated with increasing amounts of purified
35S-labeled Rfc4 protein that was synthesized in an in
vitro translation reaction. After the wells were washed, the level of
bound Rfc4 was determined by scintillation counting. As shown in Fig.
3A, wells coated with wild-type RPA bound
increasing amounts of wild-type 35S-Rfc4 compared to the
BSA control. This result indicates that the yeast RPA complex directly
interacts with yeast Rfc4 protein. When RPA was incubated with mutant
35S-Rfc4-2 protein, much less protein was retained. At
maximal input only half as much Rfc4-2 protein bound RPA (Fig. 3A). As
described below, we found that rfc4-2 is synthetically
lethal with several previously characterized rfa1 alleles.
When this assay was performed using RPA containing the
rfa1-t11 mutation (RPA-t11), we found that it bound less
35S-Rfc4 than did wild-type RPA. Further, when incubated
with mutant 35S-Rfc4-2 protein, the mutant RPA-t11 bound
even less Rfc4 protein (Fig. 3A). This combination of mutant proteins
revealed an interaction only slightly stronger than that between Rfc4
and the control BSA protein. These results suggest that the synthetic
lethality between these mutant alleles is due to a compromised
interaction between RPA1 and Rfc4.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 3.
An interaction between Rfc4 and RPA. (A) The physical
interaction between Rfc4 and the RPA complex was tested by coating
ELISA wells with 0.5 µg of either purified wild-type RPA (squares),
mutant RPA-t11 (circles) or BSA (triangles) and treating the wells with
increasing amounts of purified 35S-labeled wild-type Rfc4
(closed symbols) or mutant Rfc4-2 (open symbols). The counts per minute
(cpm) representing bound 35S-Rfc4 was determined by
scintillation counting and is plotted relative to the cpm of input
35S-Rfc4. (B) Allele-specific interaction between
RFC4 and RFA1. Strains HSY636 (RFC4
rfa1 ; left and middle columns) and HSY740 (rfc4-2
rfa1 ; right column) carrying pJM195 (RFA1/URA3) were
transformed with wild-type RFA1 or the indicated
rfa1 alleles on a LEU2-based vector.
Transformants were streaked onto plates lacking leucine and then were
taken from the plates and serially diluted 1:10. Approximately 5 µl
of each dilution was transferred to a YPD plate, a YPD plate containing
HU, or a plate containing 5-FOA to measure synthetic lethality.
|
|
To test the specificity of the interaction genetically, we examined the
viability of rfc4-2 in combination with a variety of
rfa1 alleles. Umezu and colleagues have isolated a large
group of rfa1 alleles based on their sensitivity to MMS
(75). This group of alleles covers a wide range of MMS
sensitivity and includes mutations covering all four functional domains
of Rpa1 (75). We transformed strain HSY740 (rfc4-2
rfa1
pJM195/RFA1/URA3) with 19 different
rfa1 alleles and tested for a synthetic-lethal phenotype by
measuring growth on 5-FOA. For a quantitative comparison we spotted
serial dilutions of the transformants onto plates containing 5-FOA and
compared their growth to the rfa1 single mutants as controls. Of the 19 alleles tested, four grew well on YPD but showed
little or no growth on 5-FOA (Fig. 3B): rfa1-t22 (F15L, M49T), -t11 (K45E), -t69 (K45E, D121G) and
-t48 (L221P). By comparison, RFA1 and
rfa1-t6 allowed good growth on 5-FOA (Fig. 3B).
Interestingly, all four synthetic-lethal rfa1 mutations map
in or near the N-terminal domain of Rpa1. In contrast, alleles with
mutations that map in the ssDNA binding domains are viable in
combination with rfc4-2 (data not shown). Thus,
rfc4-2 displays allele-specific interactions with
RFA1.
We tested whether this allele specificity correlated with other
rfa1 phenotypes. Synthetic lethality did correlate with the severity of the allele as judged by MMS sensitivity. However, several
rfa1 mutants that were partially MMS sensitive, temperature sensitive, or extremely defective in the repair of HO-induced DNA
breakage showed no defect in the rfc4-2 background
(75). When the 19 rfa1 single mutants were
tested for sensitivity to HU, we found that the four synthetic-lethal
rfa1 alleles also showed the strongest HU sensitivity (Fig.
3B). By comparison, rfa1-t6 was neither synthetically lethal
with rfc4-2 nor sensitive to HU. We conclude that the
synthetic-lethal phenotype of the rfa1 alleles correlates
strongly with HU sensitivity. This suggests that these interacting
genes might share defects in DNA replication checkpoint pathways
(17, 49, 60, 66, 83).
RFC4 is required for the replication block checkpoint
response.
To determine whether rfc4-2 cells respond
appropriately to a DNA replication block, we examined the viability of
rfc4-2 mutant cells in the presence of HU. When the assay
was carried out in liquid media containing 200 mM HU, rfc4-2
cells showed a mild sensitivity relative to wild-type cells (Fig.
4A). Control cells containing
rad53-K227A, a kinase-defective allele of the checkpoint kinase Rad53 (2, 20), were strongly sensitive to HU. Both of these mutants displayed a severe growth defect in the presence of
continuous HU exposure, although very tiny rfc4-2 colonies were were able to form on plates containing HU (Fig. 4B).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 4.
The rfc4-2 mutant is defective in the DNA
replication block checkpoint response. (A) HU sensitivity of
rfc4-2 cells. Strains W303-1a (wild type), HSY1025
(rfc4-2), and Y00684 (rad53-K227A) were grown to
early log phase in liquid YPD, and HU was added to a final
concentration of 200 mM. At the indicated times an aliquot was removed
and a volume containing approximately 300 cells was spread onto a YPD
plate. The percent viability was determined by counting colonies after
3 days. (B) Sensitivity of rfc4-2 cells to continuous HU
exposure. The three strains used in panel A, along with the
rfa1-t69 mutant, were streaked onto YPD plates, with or
without 100 mM HU, and were incubated at 30°C for 3 days. (C)
Phosphorylation of Rad53 in response to HU treatment. Strains W303-1a
(WT), HSY1027 (rfc4), and Y00684 (rad53) were
synchronized by treatment with -factor (lanes 1, 2, and 3) and were
released into liquid YPD medium containing 200 mM HU for 1 h (lanes 4, 5, and 6). The cells were harvested, and whole cell extracts were
prepared. Extracts were resolved by SDS-10% PAGE and were Western
blotted using an antiserum against Rad53. Asterisks (*) denote
nonspecific bands. Rad53-P denotes phosphorylated forms of Rad53.
|
|
To test whether the HU sensitivity of rfc4-2 cells reflects
a defect in the DNA replication block checkpoint response, we assayed
Rad53 phosphorylation in the presence of HU. RAD53 encodes a
protein kinase and is an essential transducer in checkpoint pathways
together with MEC1 (2, 5, 33, 58, 64, 67, 87,
90). Rad53 is phosphorylated in response to both DNA damage and
inhibition of DNA replication, and the phosphorylation of Rad53 is an
essential step in the signaling of checkpoints (16, 55,
58). Wild-type and mutant cells were synchronized in
G1 by treatment with
-factor, were released into YPD
media containing 200 mM HU, and then were analyzed for Rad53
phosphorylation. In the absence of HU, Rad53 was not phosphorylated in
G1-arrested wild-type or mutant cells (Fig. 4C, lanes 1, 2, and 3). Following HU treatment, Rad53 was completely phosphorylated in
wild-type cells; all unphosphorylated forms of Rad53 disappeared (Fig.
4C, lane 4). In contrast, the phosphorylation of Rad53 was reduced in
the rfc4-2 mutant following HU treatment. Both
unphosphorylated and phosphorylated forms of Rad53 were present in
rfc4-2 mutant cells after replication block (Fig. 4C, lane
5). In rad53-K227A control cells, both forms of Rad53
disappeared after HU treatment as observed previously (77)
(Fig. 4C, lane 6). Thus, rfc4-2 cells are partially
defective in the activation of the replication block checkpoint pathway.
RFC4 is required for the intra-S checkpoint.
DNA
damage by continuous exposure to MMS significantly extends the length
of the S phase in wild-type cells (9, 52, 53, 61, 80).
This response is distinguished from the replication block pathway in
that it requires the function of RAD9 and other genes
(53). To determine whether RFC4 is required for
the intra-S checkpoint, cells were synchronized in G1 with
-factor and were released into YPD media containing 0.038% MMS, and
aliquots of cells were removed every 30 min and treated for
microfluorometric analysis. The rate of S-phase progression in
wild-type and rfc4-2 mutant cells was then monitored by
FACS. In the absence of MMS, wild-type and rfc4-2 mutant
cells finished DNA synthesis 60 min after release from the
-factor
block (Fig. 5A, top two histograms). In
the presence of MMS, S-phase length was extended in both wild-type and
rfc4-2 cells. However, rfc4-2 cells finished S
phase faster than the wild type; rfc4-2 cells completed
replication 150 min after
-factor release, whereas wild-type cells
were still in S phase even at 180 min (Fig. 5A, left).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 5.
The rfc4-2 mutant is defective in the intra-S
checkpoint. (A) W303-1a (WT) and HSY1027 (rfc4-2) cells were
synchronized in G1 phase with -factor and were released
into YPD containing 0.038% MMS. Aliquots were removed every 30 min,
and the MMS was neutralized. Cells were then fixed, stained, and
analyzed by FACS. As a control, cells of each type were released into
YPD in the absence of MMS and were similarly analyzed. The DNA content
of untreated control cells 60 min after -factor release is presented
in the top histograms as representative of cells having completed S
phase. (B) Wild-type and rfc4-2 cells were treated as above,
and aliquots were removed every 30 min. To analyze Rad53
phosphorylation, whole cell extracts were prepared, were resolved by
SDS-10% PAGE, and were Western blotted using an antiserum against
Rad53. The asterisk (*) denotes nonspecific bands. Rad53-P denotes
phosphorylated forms of Rad53.
|
|
The phosphorylation of Rad53 was analyzed in wild-type and
rfc4-2 cells to see whether defects in regulating the rate
of S-phase progression correlate with defects in Rad53 phosphorylation.
Wild-type cells showed significant levels of phosphorylated Rad53 while inducing S-phase delay in response to MMS exposure (Fig. 5B, left panel). On the other hand, Rad53 was only partially phosphorylated in
rfc4-2 cells in response to MMS treatment (Fig. 5B, right
panel). Compared to the wild type, the ratio of phosphorylated to
unphosphorylated forms of Rad53 was greatly reduced in
rfc4-2 cells at 180 min. This rfc4-2 phenotype
contrasts slightly with that of rfc5-1, where cells entered
G2 phase 90 min after release, and Rad53 was phosphorylated
and then dephosphorylated in response to MMS (65). Taken
together, we conclude that rfc4-2 cells are partially
defective in the intra-S checkpoint and Rad53 phosphorylation.
RFC4 is required for the DNA damage checkpoint pathway.
As
mentioned previously, Rad53 phosphorylation is also required for the
activation of the DNA damage checkpoint pathway. To examine whether
RFC4 is involved in DNA damage checkpoint control, we
analyzed Rad53 phosphorylation in response to MMS and UV irradiation. MMS was added to exponentially growing cells to a final concentration of 0.1%, and the phosphorylation of Rad53 was detected by Western blotting. In wild-type cells, unphosphorylated forms of Rad53 completely disappeared and phosphorylated forms of Rad53 with slower
mobility accumulated after MMS treatment (Fig.
6A, lane 4). However, Rad53 phosphorylation was greatly reduced in
rfc4-2 mutant cells (Fig. 6A, lane 5). As above, Rad53
disappeared in rad53-K227A cells following MMS treatment
(Fig. 6A, lane 6). We conclude that RFC4 is required for the
DNA damage checkpoint pathway.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 6.
The rfc4-2 mutant is defective in the DNA
damage checkpoint. (A) Exponentially growing cells of the indicated
genotype were incubated with or without 0.1% MMS for 1 h. Both
MMS-treated (lanes 4, 5, and 6) and -untreated (lanes 1, 2, and 3)
cells were analyzed for Rad53 phosphorylation by Western blotting. (B)
Exponentially growing wild-type and rfc4-2 cells were
treated with or without UV light (60 J/m2), were incubated
for 30 min, and then were analyzed for Rad53 phosphorylation by Western
blotting (lanes 1 and 2). In addition, wild-type and rfc4-2
cells were synchronized in G1 or G2 with
-factor or nocodazole, respectively, and were treated and analyzed
as above (lanes 3 to 6). Asterisks (*) denote nonspecific bands. (C)
The rfc4-2 mutant was tested for G2/M arrest in
response to lesions caused by cdc13. Four cdc13
cdc15 strains, DLY408 (WT), DLY409 (rad9), HSY1202
(rfc4-2), and HSY1204 (rfa1-t11), were
synchronized in G1 with -factor at 23°C. Cells were
then released from the G1 block, shifted to 36°C, and
incubated for 3.5 h. Cells were fixed and stained, and their morphology
was analyzed by fluorescence microscopy. The percentage of cells
arrested at G2/M (large budded cell with a single nucleus at the neck) or at the cdc15 arrest point
(large budded cell with two nuclei) is shown in the table in the lower
right panel. Cells with nuclear DNA stretched between the mother and
daughter compartments are not represented in the table and account for
the percentages summing to less than 100.
|
|
To determine if this defect is specific to the G1/S or
G2/M checkpoint, Rad53 phosphorylation was analyzed in
G1- or G2-arrested wild-type and
rfc4-2 mutant cells in response to UV irradiation. Exponentially growing cells were arrested in G1 with
-factor or in G2 with nocodazole and were irradiated
with UV at 60 J/m2, and the phosphorylation of Rad53 was
analyzed by Western blotting. In wild-type exponential cells, Rad53 was
completely phosphorylated following UV irradiation (Fig. 6B, top panel,
lane 2). In contrast, the phosphorylation of Rad53 was greatly reduced
in exponential-phase and G1- and G2-arrested
rfc4-2 mutant cells in response to UV. The rfc4-2
cells, regardless of their phase of the cell cycle, retain a
significant amount of unphosphorylated Rad53 in response to UV
irradiation (Fig. 6B, bottom panel, lanes 2, 4, and 6). The defect in
Rad53 phosphorylation in response to DNA damage appears to be more
pronounced than that obtained during replication block with HU.
To confirm that the G2/M checkpoint defects were not
limited to Rad53 phosphorylation, we assayed the ability of cells to arrest growth at G2 in response to DNA damage. Cells
containing the cdc13 mutation undergo DNA damage upon shift
to 36°C and arrest in G2 with a large bud and a single
nucleus. In contrast, checkpoint-defective cdc13 cells at
36°C continue into the next cell cycle. We used a cdc13
cdc15 background to measure this effect since checkpoint-defective cells are unable to exit mitosis and arrest with two nuclei (the cdc15 phenotype) (24). When an otherwise
wild-type cdc13 cdc15 mutant was shifted to 36°C, all of
the cells arrested at the G2 block. In contrast, a large
percentage (87%) of rad9 cdc13 cdc15 cells arrested with
two nuclei (Fig. 6C). When rfc4-2 cdc13 cdc15 cells were
shifted to 36°C, 40% of the cells had passed the G2 arrest point, as indicated by the presence of two nuclei. These data
confirm a G2/M checkpoint defect in rfc4-2
cells, although the effect is not as pronounced as in rad9
cells. Mutations in Rpa1 have been reported to have G1/S
and intra-S checkpoint defects but no defect in G2/M
(42). When rfa1-t11 cdc13 cdc15 mutants were
shifted to 36°C we again observed about 40% of the cells arresting
with two nuclei (Fig. 6C). We conclude that both RFC4 and
RFA1 are required for wild-type G2/M checkpoint response.
Interactions between RFC4, RAD24, and
RFA1.
DNA damage checkpoints are controlled by the
RAD9 and RAD24 epistasis groups (16, 45,
81, 82). To determine whether RFC4 belonged to either
or both of these pathways, we constructed the following double mutants
and tested their response to MMS treatment: rfc4-2
rad24
, rfc4-2 rad9
, and rfc4-2
rad53-K227A. The rfc4-2 rad9
strain showed an
enhanced sensitivity to MMS whereas the MMS sensitivity of the other
two double mutants was no greater than either single mutant (Fig.
7A and data not shown). These results
indicate that RFC4 functions as part of the RAD24 epistasis group and not RAD9. This result is consistent with
the fact that Rad24 is associated with all four small subunits of the
RFC complex (26, 27).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 7.
Genetic interactions between checkpoint genes. (A)
RAD24 and RFC4 are epistatic with respect to MMS
sensitivity. Strains of the indicated genotype were tested for MMS
sensitivity by streaking onto YPD plates with or without 0.012% MMS.
(B) Suppression of rfc4-2 HU sensitivity by high-copy-number
RAD24 or RAD53. Strain HSY1027
(rfc4-2) was transformed with RAD24 or
RAD53 genes on a 2µm plasmid. Cells were serially diluted
1:10, and 5 µl was replica plated to solid media lacking tryptophane.
(C) Extragenic suppression of rfc4-2 HU sensitivity by
rfa1 mutant alleles. Strain HSY740 (rfc4-2
rfa1 ) containing plasmid pJM195 (RFA1/URA3/ADE3) was
transformed with pHS118 (RFA1), pKU1-t6
(rfa1-t6), and pKU1-t124 (rfa1-t124).
Transformants were then streaked onto plates containing 5-FOA to remove
pJM195. The resulting strains were serially diluted 1:10, and 5 µl
was replica plated onto YPD plates with or without 100 mM HU. The
resulting strain genotypes are shown at the right of the figure. Strain
HSY636 was used as a wild-type control.
|
|
We next examined whether RAD24 and rfc4-2
interacted in the replication block checkpoint by testing if
overexpression of RAD24 or RAD53 can suppress the
HU sensitivity of the rfc4-2 mutant. We transformed the
rfc4-2 mutant strain with high-copy-number RAD24
or high-copy-number RAD53 plasmids and transferred serial dilutions of each transformant onto a plate containing HU. As observed
for the rfc5-1 mutant (60), the HU sensitivity
of rfc4-2 was partially suppressed by overexpression of
RAD24 (Fig. 7B). In contrast, high-copy-number plasmids of
the other four RFC subunits showed no effect on the HU sensitivity of
the rfc4-2 strain (data not shown). RAD53
overexpression also partially suppressed the HU sensitivity of
rfc4-2. Although other explanations are possible, the
simplest interpretation of this genetic result is that RFC4 functions upstream of RAD53 (Fig. 7B).
Given the interaction between RFC4 and RFA1, we
examined whether the HU sensitivity of rfc4-2 could be
suppressed by overexpressing RFA1 or RFA2. These
genes on high-copy-number plasmids failed to suppress this phenotype
(data not shown). On the other hand, as part of our analysis of
synthetic interactions between rfc4-2 and rfa1,
we observed that the HU sensitivity of rfc4-2 could be
suppressed by two specific rfa1 alleles out of the 19 alleles tested. As shown in Fig. 7C, the growth of an rfc4-2
strain in the presence of HU is improved when it carries
rfa1-t6 or rfa1-t124 instead of wild-type
RFA1. These rfa1 alleles result from amino acid
changes mapping to the ssDNA binding domains, not the N terminus. This
extragenic suppression further suggests that the interaction between
Rpa1 and Rfc4 is likely to be important for checkpoint signaling.
 |
DISCUSSION |
A genetic interaction between RFA1 and
RFC4.
The large subunit of replication protein A
(Rpa1) contains three ssDNA binding domains and an amino-terminal
domain of approximately 180 amino acids (Rpa1N). Although Rpa1N is
dispensable for DNA replication in vitro, it is likely to play an
important role in vivo because it is essential for viability in yeast
(11, 25, 35, 56, 85). Moreover, the most severe mutations
identified in a random mutagenesis to create MMS-sensitive
rfa1 alleles map to Rpa1N as opposed to the ssDNA binding
domains (75). To investigate the essential function of
this domain, we searched for mutations that are lethal in the presence
of the rfa1-Y29H mutation. This screen identified an allele
of RFC4 (rfc4-2) which encodes a subunit of the
eukaryotic sliding clamp loader. Since human Rpa1N is known to bind a
number of proteins (10, 41), we considered the possibility of a direct interaction between Rpa1N and Rfc4. The results of binding
assays and allele-specific lethality observed in a collection of
rfa1 rfc4-2 double mutants are consistent with this notion. The simplest interpretation of these results is that an interaction between Rpa1N and Rfc4 is essential for DNA replication in vivo.
The interaction between an ssDNA binding protein and its cognate clamp
loader appears to be conserved from bacteria to higher eukaryotes. In
E. coli, the
complex physically interacts with Ecssb.
The
subunit has been shown to mediate the binding of the
complex to the C terminus of Ecssb (34). In the human system, RPA and RFC are known to interact in multiple ways. RPA targets
RFC to the primer-template junction by inhibiting its nonspecific ssDNA
binding activity (73). RPA also plays an essential role in
the DNA polymerase switch by loading the primer-recognition complex,
which then blocks the ability of DNA polymerase
to extend the
primer (74). More recently, it was shown that RPA is
specifically needed for RFC and PCNA to remain on primed DNA and
inhibit DNA polymerase activity; inhibition is lost if Ecssb is
substituted for RPA (89). These investigators also showed that the p140, p40, and p38 subunits of human RFC are capable of
binding directly to the large subunit of human Rpa1 (89).
The results reported here indicate that RFC and RPA interact via Rfc4
and Rpa1N. Based on these results, we propose the following model to
explain rfc4-2 defects in DNA replication and the DNA damage
sensing mechanism. RPA is required at the initiation of DNA replication
and at each Okazaki fragment to bind ssDNA and stimulate DNA polymerase
(10, 71, 78). As shown in Fig. 8, RFC competes with DNA polymerase
for RPA, which results in the loading of RFC and PCNA and a switch to
processive synthesis by DNA polymerase
(73, 74, 89).
Although Rfc4-2 and Rfa1-Y29H functions are compromised, they are
individually capable of performing this step. In combination, however,
their defects are exacerbated, resulting in impaired DNA synthesis and
lethality. This interaction is likely conserved during the loading of
Rad24-Rfc2-5 in DNA damage repair (Fig. 8, right). In this example,
UV-induced DNA damage is first recognized by Rad14 (XPA in human cells)
and RPA (39, 79). Following removal of the damaged DNA,
additional RPA binds to the exposed ssDNA lesion and recruits the
Rad24-Rfc2-5 complex to the primer-template junction. The PCNA-like
complex of Rad17-Mec3-Ddc1 is subsequently loaded at the
primer-template junction. This protein assembly on the ssDNA lesion,
combined with MEC1-dependent Ddc1 hyperphosphorylation, then
activates the signal transduction pathways leading to cell cycle arrest (51). We propose that Rfc4-2 and Rfa1-Y29H are partially
impaired in their ability to load the Rad24-Rfc2-5 complex, leading to a partial defect in the DNA damage checkpoint response.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 8.
Role of the Rfc4-Rpa1 interaction in DNA replication and
DNA damage checkpoint signaling. (Left) The DNA polymerase switch
during lagging-strand synthesis is shown. The model proposes that a
direct interaction between Rpa1N, bound to the lagging strand, and Rfc4
is required to target RFC to the primer-template junction. Bound RFC
then displaces polymerase , loads the PCNA sliding clamp, and allows
processive DNA synthesis by polymerase . This reaction fails in the
presence of Rfc4-2 and Rfa1-Y29H, resulting in synthetic lethality.
(Right) The DNA damage response at a UV-induced lesion is shown. Again,
a direct interaction between Rpa1N, bound at the processed lesion, and
Rfc4 is required to target the Rad24-Rfc2-5 complex to the
primer-template junction. This complex loads the Rad17-Mec3-Ddc1
sliding clamp and activates the signal transduction pathway. This
reaction is compromised in the presence of either Rfc4-2 or Rpa1-Y29H,
resulting in partially defective checkpoint signaling.
|
|
RFC4 as a sensor in checkpoint control.
Examination of the rfc4-2 phenotype revealed a mild
sensitivity to HU, consistent with a defect in the DNA replication
block checkpoint. The RAD53 protein kinase is an essential
transducer in checkpoint pathways and is phosphorylated in response to
DNA damage and inhibition of DNA replication (16, 55, 58).
G1-arrested rfc4-2 cells show only partial Rad53
phosphorylation following release into HU; approximately half of the
Rad53 remains unphosphorylated. In contrast, when wild-type cells are
subjected to this treatment all Rad53 protein is found in the
phosphorylated form (Fig. 4). Thus, rfc4-2 cells have a
partial defect in the replication block checkpoint response consistent
with the mild HU sensitivity of the mutant. A more pronounced defect in
Rad53 phosphorylation is observed in response to DNA damage in
exponentially growing, G1- or G2-arrested
rfc4-2 mutant cells. The significant amount of
unphosphorylated Rad53 that is detected in UV-irradiated
rfc4-2 cells is notable given that the mutant is not
strongly sensitive to UV irradiation (Fig. 6B). The reason for this
discrepancy is unclear, although the DNA damage response may simply
require a lower threshold of Rad53 phosphorylation. We also cannot rule out the possibility of additional pathways for DNA damage signaling. Together, these findings indicate that RFC4 is a common
component of the checkpoint response to both unreplicated DNA and DNA damage.
Wild-type cells exhibit an intra-S checkpoint which greatly extends the
length of S phase in the presence of low levels of MMS. Although
rfc4-2 cells extend S phase under these conditions, they
complete S phase well before wild-type cells do (Fig. 5A). Similarly,
with respect to the G2/M checkpoint, essentially all wild-type cells are able to arrest growth at G2 in response
to cdc13-induced damage. In contrast, about half the
rfc4-2 cells fail to arrest under these conditions (Fig.
6C). Thus, rfc4-2 cells are partially defective in the
intra-S and G2/M checkpoints consistent with the partial
defect in DNA damage signaling. Based on these results we propose that
RFC4 plays an essential role as a sensor, upstream of
RAD53, in all the checkpoints tested in this study.
A number of DNA replication proteins, including several RFC subunits,
have been identified as sensors in checkpoint pathways (3, 49,
50, 59, 65, 66). This raises the question of the role of the
individual subunits in sensing DNA defects versus the role of the
complex as a whole. If the overall integrity of the RFC complex was
important, one might expect mutations in the small subunits to behave
similarly. Indeed, these subunits share significant sequence similarity
and are expected to be structurally redundant. Although two of the
small RFC subunits, Rfc5 in S. cerevisiae (scRfc5) and Rfc3
in Schizosaccharomyces pombe (spRfc3; orthologous to scRfc3
and human p36), are required for wild-type checkpoint function,
mutations in these subunits produce somewhat different phenotypes
(59, 65). In a wild-type RAD24 background, scrfc5-1 appears to compromise the replication block
checkpoint more than the DNA damage checkpoint (48, 65).
In contrast, mutant sprfc3 produces noticeable defects in
both the replication and DNA damage checkpoints, similar to the
scrfc4-2 mutant reported here (59). An
scrfc2 mutant, which is defective in the S/M replication block checkpoint, is sensitive to DNA damage although it has not been
tested for DNA damage checkpoint function (50). While the phenotypic variation between rfc3, rfc4, and rfc5
mutants might reflect allele-specific differences, all three mutations
appear to map to the same region of these homologs. The
scrfc4-2 and sprfc3 mutations map to RFC box VIII
(sensor 2 motif) while scrfc5-1 maps to RFC box II (P loop)
(59, 66). Based on the X-ray crystallographic analysis of
the
' subunit of the E. coli clamp loader, these two
motifs are predicted to be very close to one another in tertiary structure (28). Mutations in these motifs might therefore
be expected to have similar effects on their structure and activity.
The fact that each of the small RFC subunits is essential for viability
clearly indicates that these subunits have distinct functions. In
addition, a number of differences between the small subunits have been
detected biochemically. As mentioned above, the human p37 and p36
subunits (Rfc2 and Rfc3, respectively) do not biochemically interact
with the p70 subunit of human RPA, whereas the p40 and p38 subunits
(Rfc4 and Rfc5, respectively) do (89). In addition, Cai
and coworkers have studied the role of the conserved ATP-binding
domains of each of the individual subunits of human RFC. These
investigators have shown that mutation of p38 (Rfc5) has no effect on
the ability of RFC to support in vitro DNA synthesis. In contrast, the
identical mutation in the other four subunits inhibits the ATPase
activity of RFC as well as its ability to support in vitro DNA
synthesis (14). Differences between the small subunits are
also revealed by genetic suppression experiments. The HU and
temperature sensitivity of the scrfc2-1 mutant is
suppressible by overexpressing RFC5 (50),
whereas we observed no suppression of the HU sensitivity of
rfc4-2 by overexpressing any of the other four subunits. The
failure to suppress the rfc4-2 defect is consistent with the
notion that Rfc4-2 is defective in its interaction with Rpa1 and not
with the other four RFC subunits. In fact, partial suppression of the HU sensitivity of rfc4-2 is obtained with specific
rfa1 alleles. Taking these findings together, we suspect
that the individual RFC subunits not only have specific activities but
that they interact with distinct sets of proteins. Defects in these
interactions might explain the phenotypic differences due to mutations
in RFC2-5.
RFC4 and RAD24 checkpoint control.
Two
epistasis groups have been identified that control DNA damage
checkpoints in yeast: the RAD24 group, which includes
RAD17, MEC3, and DDC1, and the RAD9
group, which contains no other members (16, 45).
RAD24 encodes a 76-kDa protein with limited sequence similarity to the RFC proteins that has been shown to be associated with the four small subunits of RFC (26, 27, 60).
Consistent with these findings, our results place RFC4 in
the RAD24 epistasis group and extend this group to include
genes involved in DNA replication. Rad24 is known to compete with Rfc1
for Rfc2-5, as overexpression of RAD24 exacerbates the
growth defect of the rfc1 mutant (44). Surprisingly, we find that RAD24 overexpression partially
complements the HU sensitivity of the rfc4-2 mutant,
implying that RAD24 plays a role in the replication block
checkpoint. Previous studies have not revealed a role for
RAD24 in the S/M replication block checkpoint, although
there is suggestive evidence for such a role (23). In the
present case, increased levels of Rad24/Rfc2-5 mutant complexes may
have improved the efficiency of the HU response directly by participating in Rad53 phosphorylation. Alternatively, increased Rad24
protein may have further compromised the Rfc1/Rfc2-5 mutant complex and
indirectly improved the HU response by activating an alternate
checkpoint pathway. Thus, while the present data suggest that
RAD24 functions in the replication block checkpoint, we
cannot rule out an indirect mechanism for the suppression of the HU
sensitivity of the rfc4-2 mutant.
Like Rfc4, Rpa1 appears to be required for the DNA damage checkpoint at
all phases of the cell cycle. Rpa1 was previously shown to be required
for the G1/S and intra-S-phase checkpoints (42), and our results confirm that Rpa1 is also required
for the G2/M checkpoint (Fig. 6C). Recently, Rpa1 was shown
to play an additional role in DNA damage signaling. The
rfa1-t11 mutation leads to premature adaptation and
suppresses the permanent G2/M arrest of cells containing
two double-strand breaks (38). The rfa1 mutants
that display synthetic lethality with rfc4-2 share a number
of phenotypes with rfc4-2. For example, like
rfc4-2 cells, rfa1-Y29H cells display reduced
levels of Rad53 phosphorylation in response to UV irradiation at the
nonpermissive temperature (data not shown). Likewise,
rfa1-t11 cells show reduced Rad53 phosphorylation in
response to double-strand breaks (54). Thus, rfc4 and rfa1 mutants appear to be defective in
the same steps of the DNA damage checkpoint response. Although the
specific structure that initiates the checkpoint and adaptation
response is unknown, these results suggest that Rpa1N and Rfc4 might
cooperate to establish this signal.
 |
ACKNOWLEDGMENTS |
We are grateful to Richard Kolodner for generously providing
RFA1 mutants, to Christina DeCoste for assistance with FACS
analysis, and to Vincent Geli, Suzanne Shanower, David Stern, Akio
Sugino, and Ted Weinert for strains, plasmids, proteins, and
antibodies. We also thank Nancy Walworth and laboratory members for
helpful comments on the manuscript.
This work was supported by National Institutes of Health grant GM55583.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Biology and Biochemistry, Rutgers University, 679 Hoes La., CABM, Piscataway, NJ 08854. Phone: (732) 235-4197. Fax: (732) 235-4880. E-mail: brill{at}mbcl.rutgers.edu.
 |
REFERENCES |
| 1.
|
Alani, E.,
R. Thresher,
J. D. Griffith, and R. D. Kolodner.
1992.
Characterization of DNA-binding and strand-exchange stimulation properties of y-RPA, a yeast single-strand-DNA-binding protein.
J. Mol. Biol.
227:54-71[CrossRef][Medline].
|
| 2.
|
Allen, J. B.,
Z. Zhou,
W. Siede,
E. C. Friedberg, and S. J. Elledge.
1994.
The SAD1/RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast.
Genes Dev.
8:2401-2415[Abstract/Free Full Text].
|
| 3.
|
Araki, H.,
S. H. Leem,
A. Phongdara, and A. Sugino.
1995.
Dpb11, which interacts with DNA polymerase II (epsilon) in Saccharomyces cerevisiae, has a dual role in S-phase progression and at a cell cycle checkpoint.
Proc. Natl. Acad. Sci. USA
92:11791-11795[Abstract/Free Full Text].
|
| 4.
|
Bender, A., and J. R. Pringle.
1991.
Use of a screen for synthetic lethal and multicopy suppressor mutants to identify two new genes involved in morphogenesis in Saccharomyces cerevisiae.
Mol. Cell. Biol.
11:1295-1305[Abstract/Free Full Text].
|
| 5.
|
Bentley, N. J.,
D. A. Holtzman,
G. Flaggs,
K. S. Keegan,
A. DeMaggio,
J. C. Ford,
M. Hoekstra, and A. M. Carr.
1996.
The Schizosaccharomyces pombe rad3 checkpoint gene.
EMBO J.
15:6641-6651[Medline].
|
| 6.
|
Bochkarev, A.,
R. A. Pfuetzner,
A. M. Edwards, and L. Frappier.
1997.
Structure of the single-stranded-DNA-binding domain of replication protein A bound to DNA.
Nature
385:176-181[CrossRef][Medline].
|
| 7.
|
Bochkareva, E.,
L. Frappier,
A. M. Edwards, and A. Bochkarev.
1998.
The RPA32 subunit of human replication protein A contains a single-stranded DNA-binding domain.
J. Biol. Chem.
273:3932-3936[Abstract/Free Full Text].
|
| 8.
|
Bochkareva, E.,
S. Korolev, and A. Bochkarev.
2000.
The role for zinc in replication protein A.
J. Biol. Chem.
275:27332-27338[Abstract/Free Full Text].
|
| 9.
|
Boddy, M. N., and P. Russell.
1999.
DNA replication checkpoint control.
Front. Biosci.
4:D841-D848[Medline].
|
| 10.
|
Braun, K. A.,
Y. Lao,
Z. He,
C. J. Ingles, and M. S. Wold.
1997.
Role of protein-protein interactions in the function of replication protein A (RPA): RPA modulates the activity of DNA polymerase alpha by multiple mechanisms.
Biochemistry
36:8443-8454[CrossRef][Medline].
|
| 11.
|
Brill, S. J., and S. Bastin-Shanower.
1998.
Identification and characterization of the fourth single-stranded-DNA binding domain of replication protein A.
Mol. Cell. Biol.
18:7225-7234[Abstract/Free Full Text].
|
| 12.
|
Brill, S. J., and B. Stillman.
1991.
Replication factor-A from Saccharomyces cerevisiae is encoded by three essential genes coordinately expressed at S phase.
Genes Dev.
5:1589-1600[Abstract/Free Full Text].
|
| 13.
|
Brill, S. J., and B. Stillman.
1989.
Yeast replication factor-A functions in the unwinding of the SV40 origin of DNA replication.
Nature
342:92-95[CrossRef][Medline].
|
| 14.
|
Cai, J.,
N. Yao,
E. Gibbs,
J. Finkelstein,
B. Phillips,
M. O'Donnell, and J. Hurwitz.
1998.
ATP hydrolysis catalyzed by human replication factor C requires participation of multiple subunits.
Proc. Natl. Acad. Sci. USA
95:11607-11612[Abstract/Free Full Text].
|
| 15.
|
Cullmann, G.,
K. Fien,
R. Kobayashi, and B. Stillman.
1995.
Characterization of the five replication factor C genes of Saccharomyces cerevisiae.
Mol. Cell. Biol.
15:4661-4671[Abstract].
|
| 16.
|
de la Torre-Ruiz, M. A.,
C. M. Green, and N. F. Lowndes.
1998.
RAD9 and RAD24 define two additive, interacting branches of the DNA damage checkpoint pathway in budding yeast normally required for Rad53 modification and activation.
EMBO J.
17:2687-2698[CrossRef][Medline].
|
| 17.
|
Dohrmann, P. R.,
G. Oshiro,
M. Tecklenburg, and R. A. Sclafani.
1999.
RAD53 regulates DBF4 independently of checkpoint function in Saccharomyces cerevisiae.
Genetics
151:965-977[Abstract/Free Full Text].
|
| 18.
|
Erdile, L. F.,
W. D. Heyer,
R. Kolodner, and T. J. Kelly.
1991.
Characterization of a cDNA encoding the 70-kDa single-stranded DNA-binding subunit of human replication protein A and the role of the protein in DNA replication.
J. Biol. Chem.
266:12090-12098[Abstract/Free Full Text].
|
| 19.
|
Fairman, M. P., and B. Stillman.
1988.
Cellular factors required for multiple stages of SV40 replication in vitro.
EMBO J.
7:1211-1218[Medline].
|
| 20.
|
Fay, D. S.,
Z. Sun, and D. F. Stern.
1997.
Mutations in SPK1/RAD53 that specifically abolish checkpoint but not growth-related functions.
Curr. Genet.
31:97-105[CrossRef][Medline].
|
| 21.
|
Fien, K., and B. Stillman.
1992.
Identification of replication factor C from Saccharomyces cerevisiae: a component of the leading-strand DNA replication complex.
Mol. Cell. Biol.
12:155-163[Abstract/Free Full Text].
|
| 22.
|
Firmenich, A. A.,
M. Elias-Arnanz, and P. Berg.
1995.
A novel allele of Saccharomyces cerevisiae RFA1 that is deficient in recombination and repair and suppressible by RAD52.
Mol. Cell. Biol.
15:1620-1631[Abstract].
|
| 23.
|
Frei, C., and S. M. Gasser.
2000.
The yeast Sgs1p helicase acts upstream of Rad53p in the DNA replication checkpoint and colocalizes with Rad53p in S-phase-specific foci.
Genes Dev.
14:81-96[Abstract/Free Full Text].
|
| 24.
|
Gardner, R.,
C. W. Putnam, and T. Weinert.
1999.
RAD53, DUN1 and PDS1 define two parallel G2/M checkpoint pathways in budding yeast.
EMBO J.
18:3173-3185[CrossRef][Medline].
|
| 25.
|
Gomes, X. V., and M. S. Wold.
1996.
Functional domains of the 70-kilodalton subunit of human replication protein A.
Biochemistry
35:10558-10568[CrossRef][Medline].
|
| 26.
|
Green, C. M.,
H. Erdjument-Bromage,
P. Tempst, and N. F. Lowndes.
2000.
A novel Rad24 checkpoint protein complex closely related to replication factor C.
Curr. Biol.
10:39-42[CrossRef][Medline].
|
| 27.
|
Griffiths, D. J.,
N. C. Barbet,
S. McCready,
A. R. Lehmann, and A. M. Carr.
1995.
Fission yeast rad17: a homologue of budding yeast RAD24 that shares regions of sequence similarity with DNA polymerase accessory proteins.
EMBO J.
14:5812-5823[Medline].
|
| 28.
|
Guenther, B.,
R. Onrust,
A. Sali,
M. O'Donnell, and J. Kuriyan.
1997.
Crystal structure of the delta' subunit of the clamp-loader complex of E. coli DNA polymerase III.
Cell
91:335-345[CrossRef][Medline].
|
| 29.
|
Harlow, E., and D. Lane.
1988.
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 30.
|
He, Z.,
L. A. Henricksen,
M. S. Wold, and C. J. Ingles.
1995.
RPA involvement in the damage-recognition and incision steps of nucleotide excision repair.
Nature
374:566-569[CrossRef][Medline].
|
| 31.
|
Henricksen, L. A.,
C. B. Umbricht, and M. S. Wold.
1994.
Recombinant replication protein A: expression, complex formation, and functional characterization.
J. Biol. Chem.
269:11121-11132[Abstract/Free Full Text].
|
| 32.
|
Heyer, W. D.,
M. R. Rao,
L. F. Erdile,
T. J. Kelly, and R. D. Kolodner.
1990.
An essential Saccharomyces cerevisiae single-stranded DNA binding protein is homologous to the large subunit of human RP-A.
EMBO J.
9:2321-2329[Medline].
|
| 33.
|
Hoekstra, M. F.
1997.
Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family.
Curr. Opin. Genet. Dev.
7:170-175[CrossRef][Medline].
|
| 34.
|
Kelman, Z.,
A. Yuzhakov,
J. Andjelkovic, and M. O'Donnell.
1998.
Devoted to the lagging strand the subunit of DNA polymerase III holoenzyme contacts SSB to promote processive elongation and sliding clamp assembly.
EMBO J.
17:2436-2449[CrossRef][Medline].
|
| 35.
|
Kim, D. K.,
E. Stigger, and S. H. Lee.
1996.
Role of the 70-kDa subunit of human replication protein A (I). Sin |